CoChat

Short‐term stability of subtypes in the irritable bowel syndrome: prospective evaluation using the Rome III classification

Open access
Engsbro, A. L., Simren, M., Bytzer, P. · 2012 · Alimentary Pharmacology & Therapeutics
Cited by 68

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Abstract

Summary: Background In irritable bowel syndrome (IBS) subtyping is used in research and clinical practice. Knowledge of subtype stability is needed for proper design of trials and treatment strategies. Aims To evaluate the stability of Rome III IBS subtypes over time and to determine the optimal time period for prospective, diary‐based subtyping. Methods Rome III IBS patients aged 18–70 years enrolled in two identical, randomised, placebo‐controlled trials of probiotics, were included. No difference was found on stool pattern, thus patients were analysed as one group. Patients scored defaecations according to Bristol Stool Form Scale for 10 weeks. IBS subtypes were determined for all 1‐ and 2‐week periods. Subtype distribution and stool pattern over time were determined. The proportions of patients having the same subtype all weeks (stable patients) or having a predominant subtype (same subtype ≥60% of time) were determined. Results A total of 126 patients, mean age 46 ± 15 years, 72% women were included. Subtype distribution was similar over time with IBS with constipation, IBS with diarrhoea and IBS unsubtyped constituting one‐third of the population each. Even though only 18–35% had the same subtype all weeks, the majority of patients had the same subtype for ≥60% of time (82–98%). Sixty‐nine per cent had the same predominant and baseline subtypes. Two‐week data increased the proportion of stable patients, of patients with a predominant subtype, and of patients who had similar baseline and predominant subtype. Conclusions Most IBS patients change subtype over time. However, an underlying stool pattern stability was demonstrated in the majority of patients. To increase stability, we recommend 2‐week data for IBS subtyping.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1365-2036.2011.04948.x

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Cited by

See all 68

Metadata

Authors
Engsbro, A. L., Simren, M., & Bytzer, P.
Venue
Alimentary Pharmacology & Therapeutics
Publisher
Wiley
Published
2011-12-18
Volume
35
Issue
3
Pages
350-359
ISSN
  • 0269-2813 (ISSN-L)
  • 1365-2036
OpenAlex
W1534144106
Cited by
68
References
8
FWCI
4.37
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Short‐term stability of subtypes in the irritable bowel syndrome: prospective evaluation using the Rome III classification. https://app.cochat.ai/papers/10.1111/j.1365-2036.2011.04948.x
The paper
Engsbro, A. L., Simren, M., & Bytzer, P. (2012). Short‐term stability of subtypes in the irritable bowel syndrome: prospective evaluation using the Rome III classification. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/j.1365-2036.2011.04948.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.